Autoimmune thyroid disease during pregnancy

The Lancet Diabetes and Endocrinology

Volumn 6, Issue 7, 2018, Pages 575-586

  De Leo, Simone ^a,b,c   Pearce, Elizabeth N ^c  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN; LEVOTHYROXINE; PLACEBO; SELENIUM; THYROGLOBULIN; THYROID ANTIBODY; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; AUTOANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN;

AUTOIMMUNE THYROIDITIS; FEMALE INFERTILITY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INFERTILITY THERAPY; NERVE CELL DIFFERENTIATION; NEWBORN DISEASE; PATHOGENESIS; PLACENTAL TRANSFER; POSTPARTUM THYROIDITIS; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; AUTOIMMUNE DISEASE; COMPLICATION; DEVELOPMENTAL DISORDER; FEMALE; IMMUNOLOGY; PREGNANCY; PREMATURITY; THYROID DISEASE;

ABORTION, SPONTANEOUS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH; THYROID DISEASES;

EID: 85039070425     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(17)30402-3     Document Type: Review

References (110)

1. Alexander, EK, Pearce, EN, Brent, G, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27 (2017), 315–389.
2. Cooper, DS, Laurberg, P, Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol 1 (2013), 238–249.
3. Bucci, I, Giuliani, C, Napolitano, G, Thyroid-stimulating hormone receptor antibodies in pregnancy: clinical relevance. Front Endocrinol (Lausanne), 8, 2017, 137.
4. Korevaar, TI, de Rijke, YB, Chaker, L, et al. Stimulation of thyroid function by human chorionic gonadotropin during pregnancy: a risk factor for thyroid disease and a mechanism for known risk factors. Thyroid 27 (2017), 440–450.
5. Kahaly, GJ, Diana, T, TSH receptor antibody functionality and nomenclature. Front Endocrinol (Lausanne), 8, 2017, 28.
6. Barbesino, G, Tomer, Y, Clinical utility of TSH receptor antibodies. J Clin Endocrinol Metab 98 (2013), 2247–2255.
7. Abeillon-du Payrat, J, Chikh, K, Bossard, N, et al. Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism. Eur J Endocrinol 171 (2014), 451–460.
8. McLachlan, SM, Rapoport, B, Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid 23 (2013), 14–24.
9. Skuza, KA, Sills, IN, Stene, M, Rapaport, R, Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease. J Pediatr 128 (1996), 264–268.
10. Glinoer, D, Riahi, M, Grün, JP, Kinthaert, J, Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 79 (1994), 197–204.
11. Pearce, EN, Oken, E, Gillman, MW, et al. Association of first-trimester thyroid function test values with thyroperoxidase antibody status, smoking, and multivitamin use. Endocr Pract 14 (2008), 33–39.
12. Medici, M, de Rijke, YB, Peeters, RP, et al. Maternal early pregnancy and newborn thyroid hormone parameters: the Generation R study. J Clin Endocrinol Metab 97 (2012), 646–652.
13. Moreno-Reyes, R, Glinoer, D, Van Oyen, H, Vandevijvere, S, High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: a population-based study. J Clin Endocrinol Metab 98 (2013), 3694–3701.
14. Feki, M, Omar, S, Menif, O, et al. Thyroid disorders in pregnancy: frequency and association with selected diseases and obstetrical complications in Tunisian women. Clin Biochem 41 (2008), 927–931.
15. Blatt, AJ, Nakamoto, JM, Kaufman, HW, National status of testing for hypothyroidism during pregnancy and postpartum. J Clin Endocrinol Metab 97 (2012), 777–784.
16. Hollowell, JG, Staehling, NW, Flanders, WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87 (2002), 489–499.
17. Ashoor, G, Maiz, N, Rotas, M, Jawdat, F, Nicolaides, KH, Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death. Thyroid 20 (2010), 989–993.
18. Abbassi-Ghanavati, M, Casey, BM, Spong, CY, McIntire, DD, Halvorson, LM, Cunningham, FG, Pregnancy outcomes in women with thyroid peroxidase antibodies. Obstet Gynecol 116 (2010), 381–386.
19. Shi, X, Han, C, Li, C, et al. Optimal and safe upper limits of iodine intake for early pregnancy in iodine-sufficient regions: a cross-sectional study of 7190 pregnant women in China. J Clin Endocrinol Metab 100 (2015), 1630–1638.
20. Iijima, T, Tada, H, Hidaka, Y, Mitsuda, N, Murata, Y, Amino, N, Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol 90 (1997), 364–369.
21. Negro, R, Formoso, G, Mangieri, T, Pezzarossa, A, Dazzi, D, Hassan, H, Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 91 (2006), 2587–2591.
22. Stricker, R, Echenard, M, Eberhart, R, et al. Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol 157 (2007), 509–514.
23. Cleary-Goldman, J, Malone, FD, Lambert-Messerlian, G, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 112 (2008), 85–92.
24. Karakosta, P, Chatzi, L, Bagkeris, E, et al. First- and second-trimester reference intervals for thyroid hormones during pregnancy in “Rhea” mother-child cohort, Crete, Greece. J Thyroid Res, 2011, 2011, 490783.
25. Yehuda, M, Wang, CH, Pak, Y, Chiu, KC, Gianoukakis, AG, Parity and risk of thyroid autoimmunity based on the NHANES (2001–2002, 2007–2008, 2009–2010, and 2011–2012). J Clin Endocrinol Metab 102 (2017), 3437–3442.
26. Dussault, JH, Letarte, J, Guyda, H, Laberge, C, Lack of influence of thyroid antibodies on thyroid function in the newborn infant and on a mass screening program for congenital hypothyroidism. J Pediatr 96 (1980), 385–389.
27. Pfeifer, S, Fritz, M, Goldberg, J, et al. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 98 (2012), 1103–1111.
28. Stagnaro-Green, A, Roman, SH, Cobin, RH, el-Harazy, E, Alvarez-Marfany, M, Davies, TF, Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 264 (1990), 1422–1425.
29. Plowden, TC, Schisterman, EF, Sjaarda, LA, et al. Subclinical hypothyroidism and thyroid autoimmunity are not associated with fecundity, pregnancy loss, or live birth. J Clin Endocrinol Metab 101 (2016), 2358–2365.
30. Thangaratinam, S, Tan, A, Knox, E, Kilby, MD, Franklyn, J, Coomarasamy, A, Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ, 342, 2011, d2616.
31. Iravani, AT, Saeedi, MM, Pakravesh, J, Hamidi, S, Abbasi, M, Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study. Endocr Pract 14 (2008), 458–464.
32. Lata, K, Dutta, P, Sridhar, S, et al. Thyroid autoimmunity and obstetric outcomes in women with recurrent miscarriage: a case-control study. Endocr Connect 2 (2013), 118–124.
33. Mecacci, F, Parretti, E, Cioni, R, et al. Thyroid autoimmunity and its association with non-organ-specific antibodies and subclinical alterations of thyroid function in women with a history of pregnancy loss or preeclampsia. J Reprod Immunol 46 (2000), 39–50.
34. Esplin, MS, Branch, DW, Silver, R, Stagnaro-Green, A, Thyroid autoantibodies are not associated with recurrent pregnancy loss. Am J Obstet Gynecol 179 (1998), 1583–1586.
35. Rushworth, FH, Backos, M, Rai, R, Chilcott, IT, Baxter, N, Regan, L, Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod 15 (2000), 1637–1639.
36. van den Boogaard, E, Vissenberg, R, Land, JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update 17 (2011), 605–619.
37. Chen, L, Hu, R, Thyroid autoimmunity and miscarriage: a meta-analysis. Clin Endocrinol (Oxf) 74 (2011), 513–519.
38. Schneuer, FJ, Nassar, N, Tasevski, V, Morris, JM, Roberts, CL, Association and predictive accuracy of high TSH serum levels in first trimester and adverse pregnancy outcomes. J Clin Endocrinol Metab 97 (2012), 3115–3122.
39. Liu, H, Shan, Z, Li, C, et al. Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study. Thyroid 24 (2014), 1642–1649.
40. Lazzarin, N, Moretti, C, De Felice, G, Vaquero, E, Manfellotto, D, Further evidence on the role of thyroid autoimmunity in women with recurrent miscarriage. Int J Endocrinol, 2012, 2012, 717185.
41. Kim, NY, Cho, HJ, Kim, HY, et al. Thyroid autoimmunity and its association with cellular and humoral immunity in women with reproductive failures. Am J Reprod Immunol 65 (2011), 78–87.
42. Roberts, J, Jenkins, C, Wilson, R, et al. Recurrent miscarriage is associated with increased numbers of CD5/20 positive lymphocytes and an increased incidence of thyroid antibodies. Eur J Endocrinol 134 (1996), 84–86.
43. Kwak-Kim, JY, Chung-Bang, HS, Ng, SC, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 18 (2003), 767–773.
44. Konova, E, The role of NK cells in the autoimmune thyroid disease-associated pregnancy loss. Clin Rev Allergy Immunol 39 (2010), 176–184.
45. Lee, YL, Ng, HP, Lau, KS, et al. Increased fetal abortion rate in autoimmune thyroid disease is related to circulating TPO autoantibodies in an autoimmune thyroiditis animal model. Fertil Steril 91:suppl 5 (2009), 2104–2109.
46. Matalon, ST, Blank, M, Levy, Y, et al. The pathogenic role of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice. Hum Reprod 18 (2003), 1094–1099.
47. Twig, G, Shina, A, Amital, H, Shoenfeld, Y, Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity. J Autoimmun 38 (2012), J275–J281.
48. Toulis, KA, Goulis, DG, Venetis, CA, Kolibianakis, EM, Tarlatzis, BC, Papadimas, I, Thyroid autoimmunity and miscarriages: the corpus luteum hypothesis. Med Hypotheses 73 (2009), 1060–1062.
49. Debiìve, F, Duliìre, S, Bernard, P, Hubinont, C, De Nayer, P, Daumerie, C, To treat or not to treat euthyroid autoimmune disorder during pregnancy?. Gynecol Obstet Invest 67 (2009), 178–182.
50. Lepoutre, T, Debiìve, F, Gruson, D, Daumerie, C, Reduction of miscarriages through universal screening and treatment of thyroid autoimmune diseases. Gynecol Obstet Invest 74 (2012), 265–273.
51. Vissenberg, R, Fliers, E, van der Post, JA, van Wely, M, Bisschop, PH, Goddijn, M, Live-birth rate in euthyroid women with recurrent miscarriage and thyroid peroxidase antibodies. Gynecol Endocrinol 32 (2016), 132–135.
52. Negro, R, Schwartz, A, Stagnaro-Green, A, Impact of levothyroxine in miscarriage and preterm delivery rates in first trimester thyroid antibody-positive women with TSH less than 2·5 mIU/L. J Clin Endocrinol Metab 101 (2016), 3685–3690.
53. Nazarpour, S, Ramezani Tehrani, F, Simbar, M, Tohidi, M, Alavi Majd, H, Azizi, F, Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease. Eur J Endocrinol 176 (2017), 253–265.
54. Vissenberg, R, van den Boogaard, E, van Wely, M, et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Hum Reprod Update 18 (2012), 360–373.
55. De Groot, L, Abalovich, M, Alexander, E, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97 (2012), 2543–2565.
56. Birmingham Clinical Trials Unit, Randomised controlled trial of the efficacy and mechanism of levothyroxine treatment on pregnancy and neonatal outcomes in women with thyroid antibodies (TABLET). Birmingham: University of Birmingham. http://www.birmingham.ac.uk/research/activity/mds/trials/bctu/trials/womens/tablet/index.aspx, 2017. (Accessed 5 October 2017)
57. Vissenberg, R, van Dijk, MM, Fliers, E, et al. Effect of levothyroxine on live birth rate in euthyroid women with recurrent miscarriage and TPO antibodies (T4-LIFE study). Contemp Clin Trials 44 (2015), 134–138.
58. Yamada, H, Morikawa, M, Furuta, I, et al. Intravenous immunoglobulin treatment in women with recurrent abortions: increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood. Am J Reprod Immunol 49 (2003), 84–89.
59. Stricker, RB, Steinleitner, A, Bookoff, CN, Weckstein, LN, Winger, EE, Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin. Fertil Steril 73 (2000), 536–540.
60. Kiprov, DD, Nachtigall, RD, Weaver, RC, Jacobson, A, Main, EK, Garovoy, MR, The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am J Reprod Immunol 36 (1996), 228–234.
61. Vaquero, E, Lazzarin, N, De Carolis, C, Valensise, H, Moretti, C, Ramanini, C, Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach. Am J Reprod Immunol 43 (2000), 204–208.
62. Martin, JA, Hamilton, BE, Osterman, MJ, Curtin, SC, Matthews, TJ, Births: final data for 2013. Natl Vital Stat Rep 64 (2015), 1–65.
63. Zeitlin, J, Szamotulska, K, Drewniak, N, et al. Preterm birth time trends in Europe: a study of 19 countries. BJOG 120 (2013), 1356–1365.
64. He, X, Wang, P, Wang, Z, He, X, Xu, D, Wang, B, Thyroid antibodies and risk of preterm delivery: a meta-analysis of prospective cohort studies. Eur J Endocrinol 167 (2012), 455–464.
65. Korevaar, TI, Steegers, EA, Pop, VJ, et al. Thyroid autoimmunity impairs the thyroidal response to human chorionic gonadotropin: two population-based prospective cohort studies. J Clin Endocrinol Metab 102 (2017), 69–77.
66. Monteleone, P, Parrini, D, Faviana, P, et al. Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. Am J Reprod Immunol 66 (2011), 108–114.
67. Geva, E, Vardinon, N, Lessing, JB, et al. Organ-specific autoantibodies are possible markers for reproductive failure: a prospective study in an in-vitro fertilization-embryo transfer programme. Hum Reprod 11 (1996), 1627–1631.
68. Zhong, YP, Ying, Y, Wu, HT, et al. Relationship between antithyroid antibody and pregnancy outcome following in vitro fertilization and embryo transfer. Int J Med Sci 9 (2012), 121–125.
69. Łukaszuk, K, Kunicki, M, Kulwikowska, P, et al. The impact of the presence of antithyroid antibodies on pregnancy outcome following intracytoplasmatic sperm injection-ICSI and embryo transfer in women with normal thyreotropine levels. J Endocrinol Invest 38 (2015), 1335–1343.
70. Tan, S, Dieterle, S, Pechlavanis, S, Janssen, OE, Fuhrer, D, Thyroid autoantibodies per se do not impair intracytoplasmic sperm injection outcome in euthyroid healthy women. Eur J Endocrinol 170 (2014), 495–500.
71. Unuane, D, Velkeniers, B, Bravenboer, B, et al. Impact of thyroid autoimmunity in euthyroid women on live birth rate after IUI. Hum Reprod 32 (2017), 915–922.
72. Sakar, MN, Unal, A, Atay, AE, et al. Is there an effect of thyroid autoimmunity on the outcomes of assisted reproduction?. J Obstet Gynaecol 36 (2016), 213–217.
73. Toulis, KA, Goulis, DG, Venetis, CA, et al. Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis. Eur J Endocrinol 162 (2010), 643–652.
74. Busnelli, A, Paffoni, A, Fedele, L, Somigliana, E, The impact of thyroid autoimmunity on IVF/ICSI outcome: a systematic review and meta-analysis. Hum Reprod Update 22 (2016), 793–794.
75. Poppe, K, Glinoer, D, Tournaye, H, et al. Assisted reproduction and thyroid autoimmunity: an unfortunate combination?. J Clin Endocrinol Metab 88 (2003), 4149–4152.
76. Revelli, A, Casano, S, Piane, LD, et al. A retrospective study on IVF outcome in euthyroid patients with anti-thyroid antibodies: effects of levothyroxine, acetyl-salicylic acid and prednisolone adjuvant treatments. Reprod Biol Endocrinol, 7, 2009, 137.
77. Negro, R, Mangieri, T, Coppola, L, et al. Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum Reprod 20 (2005), 1529–1533.
78. Sher, G, Maassarani, G, Zouves, C, et al. The use of combined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies. Am J Reprod Immunol 39 (1998), 223–225.
79. Turi, A, Giannubilo, SR, Zanconi, S, Mascetti, A, Tranquilli, AL, Preconception steroid treatment in infertile women with antithyroid autoimmunity undergoing ovarian stimulation and intrauterine insemination: a double-blind, randomized, prospective cohort study. Clin Ther 32 (2010), 2415–2421.
80. Litwicka, K, Arrivi, C, Varricchio, MT, Mencacci, C, Greco, E, In women with thyroid autoimmunity, does low-dose prednisolone administration, compared with no adjuvant therapy, improve in vitro fertilization clinical results?. J Obstet Gynaecol Res 41 (2015), 722–728.
81. Pop, VJ, de Vries, E, van Baar, AL, et al. Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development?. J Clin Endocrinol Metab 80 (1995), 3561–3566.
82. Li, Y, Shan, Z, Teng, W, et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol (Oxf) 72 (2010), 825–829.
83. Williams, FL, Watson, J, Ogston, SA, Visser, TJ, Hume, R, Willatts, P, Maternal and umbilical cord levels of T4, FT4, TSH, TPOAb, and TgAb in term infants and neurodevelopmental outcome at 5·5 years. J Clin Endocrinol Metab 98 (2013), 829–838.
84. Ghassabian, A, Bongers-Schokking, JJ, de Rijke, YB, et al. Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: the Generation R Study. Thyroid 22 (2012), 178–186.
85. Wasserman, EE, Pillion, JP, Duggan, A, et al. Childhood IQ, hearing loss, and maternal thyroid autoimmunity in the Baltimore Collaborative Perinatal Project. Pediatr Res 72 (2012), 525–530.
86. Wasserman, EE, Nelson, K, Rose, NR, et al. Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: an epidemiologic assessment. Am J Epidemiol 167 (2008), 701–710.
87. Männistö, T, Vääräsmäki, M, Pouta, A, et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab 94 (2009), 772–779.
88. Tong, Z, Xiaowen, Z, Baomin, C, et al. The effect of subclinical maternal thyroid dysfunction and autoimmunity on intrauterine growth restriction: a systematic review and meta-analysis. Medicine (Baltimore), 95, 2016, e3677.
89. Negro, R, Schwartz, A, Gismondi, R, Tinelli, A, Mangieri, T, Stagnaro-Green, A, Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. J Clin Endocrinol Metab 96 (2011), E920–E924.
90. Dama, M, Steiner, M, Lieshout, RV, Thyroid peroxidase autoantibodies and perinatal depression risk: a systematic review. J Affect Disord 198 (2016), 108–121.
91. Zhou, Y, Wang, X, Zhao, Y, et al. Elevated thyroid peroxidase antibody increases risk of post-partum depression by decreasing prefrontal cortex BDNF and 5-HT levels in mice. Front Cell Neurosci, 10, 2017, 307.
92. Postal, M, Appenzeller, S, The importance of cytokines and autoantibodies in depression. Autoimmun Rev 14 (2015), 30–35.
93. Ying, H, Tang, YP, Bao, YR, et al. Maternal TSH level and TPOAb status in early pregnancy and their relationship to the risk of gestational diabetes mellitus. Endocrine 54 (2016), 742–750.
94. Yang, Y, Li, Q, Wang, Q, Ma, X, Thyroid antibodies and gestational diabetes mellitus: a meta-analysis. Fertil Steril 104 (2015), 665–671.
95. Haddow, JE, McClain, MR, Palomaki, GE, et al. Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption. Obstet Gynecol 117 (2011), 287–292.
96. Haddow, JE, Cleary-Goldman, J, McClain, MR, et al. Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery. Obstet Gynecol 116 (2010), 58–62.
97. Chen, LM, Zhang, Q, Si, GX, et al. Associations between thyroid autoantibody status and abnormal pregnancy outcomes in euthyroid women. Endocrine 48 (2015), 924–928.
98. Korevaar, TI, Schalekamp-Timmermans, S, de Rijke, YB, et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study. J Clin Endocrinol Metab 98 (2013), 4382–4390.
99. Chen, X, Jin, B, Xia, J, et al. Effects of thyroid peroxidase antibody on maternal and neonatal outcomes in pregnant women in an iodine-sufficient area in China. Int J Endocrinol, 2016, 2016, 6461380.
100. Stagnaro-Green, A, Schwartz, A, Gismondi, R, Tinelli, A, Mangieri, T, Negro, R, High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in southern Italy. J Clin Endocrinol Metab 96 (2011), 652–657.
101. Nicholson, WK, Robinson, KA, Smallridge, RC, Ladenson, PW, Powe, NR, Prevalence of postpartum thyroid dysfunction: a quantitative review. Thyroid 16 (2006), 573–582.
102. Premawardhana, LD, Parkes, AB, John, R, Harris, B, Lazarus, JH, Thyroid peroxidase antibodies in early pregnancy: utility for prediction of postpartum thyroid dysfunction and implications for screening. Thyroid 14 (2004), 610–615.
103. Ekinci, EI, Chiu, WL, Lu, ZX, et al. A longitudinal study of thyroid autoantibodies in pregnancy: the importance of test timing. Clin Endocrinol (Oxf) 82 (2015), 604–610.
104. Azizi, F, The occurrence of permanent thyroid failure in patients with subclinical postpartum thyroiditis. Eur J Endocrinol 153 (2005), 367–371.
105. Kämpe, O, Jansson, R, Karlsson, FA, Effects of L-thyroxine and iodide on the development of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab 70 (1990), 1014–1018.
106. Nøhr, SB, Jørgensen, A, Pedersen, KM, Laurberg, P, Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe?. J Clin Endocrinol Metab 85 (2000), 3191–3198.
107. Negro, R, Greco, G, Mangieri, T, Pezzarossa, A, Dazzi, D, Hassan, H, The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 92 (2007), 1263–1268.
108. Mao, J, Pop, VJ, Bath, SC, Vader, HL, Redman, CW, Rayman, MP, Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-to-moderate iodine deficiency. Eur J Nutr 55 (2016), 55–61.
109. Stranges, S, Marshall, JR, Natarajan, R, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 147 (2007), 217–223.
110. Winther, KH, Watt, T, Bjørner, JB, et al. The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial. Trials, 15, 2014, 115.